Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry: Best practice recommendations for standardization of immunohistochemistry tests

American Journal of Clinical Pathology

Volumn 133, Issue 3, 2010, Pages 354-365

  Torlakovic, Emina Emilia ^a   Riddell, Robert ^b   Banerjee, Diponkar ^c   El Zimaity, Hala ^d   Pilavdzic, Dragana ^e   Dawe, Peter ^f   Magliocco, Anthony ^g   Barnes, Penny ^h   Berendt, Richard ⁱ   Cook, Donald ^j   Gilks, Blake ^k   Williams, Gaynor ^l   Perez Ordonez, Bayardo ^m   Wehrli, Bret ⁿ   Swanson, Paul E ^o   Otis, Christopher N ^p   Nielsen, Søren ^q   Vyberg, Mogens ^q   Butany, Jagdish ^m  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c PROVINCIAL HEALTH SERVICES AUTHORITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f Societe canadienne du cancer   (Canada)

^g TOM BAKER CANCER CENTRE   (Canada)

^h QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

ⁱ CROSS CANCER INSTITUTE   (Canada)

^j St Clare's Mercy Hospital   (Canada)

^k VANCOUVER GENERAL HOSPITAL   (Canada)

^l UNIVERSITY OF MANITOBA   (Canada)

^m UNIVERSITY HEALTH NETWORK   (Canada)

ⁿ LONDON HEALTH SCIENCES CENTRE   (Canada)

^o UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^p TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q AALBORG UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

Canadian Association of Pathologists; Clinical immunohistochemistry; Standards

Indexed keywords

ANTIBODY;

ARTICLE; CALIBRATION; CLINICAL EDUCATION; HEALTH CARE PERSONNEL; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MEDICAL SOCIETY; NEOPLASM; NOMENCLATURE; PRIORITY JOURNAL; PROGNOSIS; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; STANDARDIZATION; TISSUE TYPES; VALIDATION STUDY; CLASSIFICATION; METHODOLOGY; STANDARD; TISSUE FIXATION; TISSUE MICROARRAY;

HUMANS; IMMUNOHISTOCHEMISTRY; QUALITY CONTROL; REFERENCE STANDARDS; RESEARCH DESIGN; TISSUE ARRAY ANALYSIS; TISSUE FIXATION; VALIDATION STUDIES AS TOPIC;

EID: 77949397817     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPDYZ1XMF4HJWK     Document Type: Article

References (38)

1. Elias JM. Immunohistochemical methods. In: Immunohistopathology: A Practical Approach to Diagnosis. 2nd ed. Chicago, IL: ASCP Press; 2003:1-110.
2. Taylor CR, Shi S-R, Barr NJ, et al. Techniques of immunohistochemistry: principles, pitfalls, and standardization. In: Dabbs D, ed. Diagnostic Immunohistochemistry. 2nd ed. New York, NY: Churchill Livingstone Elsevier; 2006:1-42.
3. Taylor CR, Cote RJ. Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologists. 3rd ed. Philadelphia, PA: Saunders; 2005:26-28.
4. Major Problems in Pathology; vol 19.
5. Nagle RB, Fitzgibbons PL. Consensual interpretive guidelines for diagnostic immunohistochemistry [letter]. Am J Surg Pathol. 2002;26:816-817.
6. O'Leary TJ. Standardization in immunohistochemistry. Appl Immunohistochem Mol Morphol. 2001;9:3-8.
7. National Committee for Clinical Laboratory Standards. Quality Assurance for Immunocytochemistry; Approved guideline. NCCLS document MM4-AC. Wayne, PA: National Committee for Clinical Laboratory Standards; 1999.
8. Ramos-Vara JA, Kiupel M, Baszler T, et al. Suggested guidelines for immunohistochemical techniques in veterinary diagnostic laboratories. J Vet Diagn Invest. 2008;20:393-413.
9. Shi SR, Liu C, Taylor CR. Standardization of immunohistochemistry for formalin-fixed, paraffin-embedded tissue sections based on the antigen-retrieval technique: from experiments to hypothesis. J Histochem Cytochem. 2007;55:105-109. (Pubitemid 46147687)
10. Taylor CR. The total test approach to standardization of immunohistochemistry. Arch Pathol Lab Med. 2000;124:945-951.
11. Goldstein NS, Hewitt SM, Taylor CR, et al; Members of Ad-Hoc Committee on Immunohistochemistry Standardization. Recommendations for improved standardization of immunohistochemistry. Appl Immunohistochem Mol Morphol. 2007;15:124-133.
12. Dabbs DJ, Abendroth CS, Grenko RT, et al. Immunocytochemistry on the ThinPrep processor. Diagn Cytopathol. 1997;17:388-392.
13. Wiatrowska BA, Berner A, Torlakovic G, et al. Cultured anaplastic cell lines as immunocytochemistry controls: a comparison of ThinPrep-processed smears and conventional air-dried Cytospins. Diagn Cytopathol. 2001;25:303-308. (Pubitemid 33048803)
14. Tafjord S, Behler PJ, Risberg B, et al. Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry. Diagn Cytopathol. 2002;26:137-141. (Pubitemid 34195273)
15. Goldstein NS, Ferkowicz M, Odish E, et al. Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma. Am J Clin Pathol. 2003;120:86-92. (Pubitemid 37046374)
16. Seidal T, Balaton AJ, Battifora H. Interpretation and quantification of immunostains. Am J Surg Pathol. 2001;25:1204-1207.
17. US Department of Health and Human Services, Food and Drug Administration Center for Devices and Radiological Health, Immunology Branch, Division of Clinical Laboratory Devices, Office of Device Evaluation. Guidance for Submission of Immunohistochemistry Applications to the FDA: Final Guidance for Industry. June 3, 1998. http://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/ucm094002.htm. Accessed January 18, 2010.
18. Taylor CR. FDA issues final rule for classification and reclassification of immunochemistry reagents and kits [editorial]. Am J Clin Pathol. 1999;111:443-444.
19. Leong AS. Quantitation in immunohistology: fact or fiction? a discussion of variables that influence results. Appl Immunohistochem Mol Morphol. 2004;12:1-7.
20. Wolff AC, Hammond ME, Schwarz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25:118-145. (Pubitemid 350003059)
21. Rhodes A, Jasani B, Anderson E, et al. Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries. Am J Clin Pathol. 2002;118:408-417. (Pubitemid 37046339)
22. Rhodes A, Jasani B, Balaton AJ, et al. Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J Clin Pathol. 2000;53:292-301. (Pubitemid 30180402)
23. Hammond ME, Fitzgibbons PL, Compton CC, et al; for the Members of the Cancer Committee and Conference Participants. College of American Pathologists Conference XXXV: solid tumor prognostic factors: which, how, and so what? summary document and recommendations for implementation. Arch Pathol Lab Med. 2000;124:958-965.
24. Gown AM. Current issues in ER and HER2 testing by IHC in breast cancer. Mod Pathol. 2008;21(suppl 2):S8-S15.
25. Rhodes A, Jasani B, Couturier J, et al. A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer. Am J Clin Pathol. 2002;117:81-89. (Pubitemid 34052476)
26. Hanna W, O'Malley FP, Barnes P, et al. Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer. Curr Oncol. 2007;14:149-153.
27. Terry J, Torlakovic EE, Garratt J, et al. Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in Immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/ Immunohistochemistry. Appl Immunohistochem Mol Morphol. 2009;17:375-382.
28. Yaziji H, Taylor CR, Goldstein NS, et al; Members of the Standardization Ad-Hoc Consensus Committee. Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry. Appl Immunohistochem Mol Morphol. 2008;16:513-520.
29. Shi SR, Liu C, Perez J, et al. Protein-embedding technique: a potential approach to standardization of immunohistochemistry for formalin-fixed, paraffin-embedded tissue sections. J Histochem Cytochem. 2005;53:1167-1170. (Pubitemid 41262985)
30. Taylor CR. Quantifiable internal reference standards for immunohistochemistry: the measurement of quantity by weight. Appl Immunohistochem Mol Morphol. 2006;14:253-259.
31. Statland BE, Westgard JO. Quality management. In: Henry JB, ed. Clinical Diagnosis and Management by Laboratory Methods. Philadelphia, PA: Saunders; 1991:81-100.
32. Yazdi HM, Dardick I. Diagnostic Immunocytochemistry and Electron Microscopy. New York, NY: Igaku-Shoin; 1992:34-40.
33. Kurtycz DF, Logrono R, Leopando M, et al. Immunocytochemistry controls using cell culture. Diagn Cytopathol. 1997;17:74-79. (Pubitemid 27278698)
34. Torlakovic EE, Naresh K, Kremer M, et al. Call for a European programme in external quality assurance for bone marrow immunohistochemistry: report of a European Bone Marrow Working Group pilot study. J Clin Pathol. 2009;62:547-551.
35. Taylor CR, Levenson RM. Quantification of immunohistochemistry: issues concerning methods, utility and semiquantitative assessment II. Histopathology. 2006;49:411-424. (Pubitemid 44401549)
36. Rasmussen OF. Controls. In: Key M, ed. Immunohistochemical Staining Methods: DAKO Education Guide. 4th ed. Carpinteria, CA: DAKO; 2006:113-118.
37. Turbin DA, Leung S, Cheang MC, et al. Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases. Breast Cancer Res Treat. 2008;110:417-426. (Pubitemid 351962583)
38. Hsu F, Nielsen TO, Alkushi A, et al. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol. 2002;15:1374-1380.